Display options
Cite
Szczepek AJ, Stankovic KM. Editorial: Emerging Ototoxic Medications and Their Role in Cochlear and Vestibular Disorders. Front Neurol. 2021;12:773714doi: 10.3389/fneur.2021.773714.
Szczepek, A. J., & Stankovic, K. M. (2021). Editorial: Emerging Ototoxic Medications and Their Role in Cochlear and Vestibular Disorders. Frontiers in neurology, 12773714. https://doi.org/10.3389/fneur.2021.773714
Szczepek, Agnieszka J, and Stankovic, Kostantina M. "Editorial: Emerging Ototoxic Medications and Their Role in Cochlear and Vestibular Disorders." Frontiers in neurology vol. 12 (2021): 773714. doi: https://doi.org/10.3389/fneur.2021.773714
Szczepek AJ, Stankovic KM. Editorial: Emerging Ototoxic Medications and Their Role in Cochlear and Vestibular Disorders. Front Neurol. 2021 Oct 22;12:773714. doi: 10.3389/fneur.2021.773714. eCollection 2021. PMID: 34744994; PMCID: PMC8569918.
Copy Download .nbib Format: NLM
Share it on

Front Neurol. 2021 Oct 22;12:773714. doi: 10.3389/fneur.2021.773714. eCollection 2021.

Editorial: Emerging Ototoxic Medications and Their Role in Cochlear and Vestibular Disorders.

Frontiers in neurology

Agnieszka J Szczepek, Kostantina M Stankovic

Affiliations

  1. Department of Otorhinolaryngology, Head and Neck Surgery, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  2. Faculty of Medicine and Health Sciences, University of Zielona Gora, Zielona Gora, Poland.
  3. Department of Otolaryngology-Head and Neck Surgery, Stanford University School of Medicine, Stanford, CA, United States.

PMID: 34744994 PMCID: PMC8569918 DOI: 10.3389/fneur.2021.773714

[No abstract available.]

Keywords: COVID-19; MDR–multi drug resistant; cochlea; medications; ototoxicity; tuberculosis; vestibular system

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  1. J Infect. 2021 Jul;83(1):27-36 - PubMed
  2. Korean J Audiol. 2013 Apr;17(1):23-6 - PubMed
  3. Hear Res. 2020 Sep 15;395:108019 - PubMed
  4. J Occup Health. 2017 Mar 28;59(2):104-111 - PubMed
  5. Bioessays. 2021 Feb;43(2):e2000163 - PubMed
  6. Pharmacotherapy. 2020 Dec;40(12):1265-1275 - PubMed
  7. Stem Cells. 2021 Jun;39(6):673-696 - PubMed
  8. Front Neurol. 2021 Feb 09;12:635359 - PubMed
  9. Nat Immunol. 2019 Jul;20(7):770-774 - PubMed
  10. Lancet. 2011 Jul 23;378(9788):369-71 - PubMed

Publication Types